Arkolith/Insider Trading/SGMT/Form 4

Hom Dennis

Chief Financial OfficerSagimet Biosciences Inc. (SGMT) · full profile →Form 4 · filed Jul 20, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 18, 2023Grant(A)137K—$0137K
Jul 18, 2023Disposed to issuer(D)137K—$00
Jul 18, 2023Grant(A)9K—$09K
Jul 18, 2023Disposed to issuer(D)9K—$00
Jul 18, 2023Grant(A)111K—$0111K
Jul 18, 2023Disposed to issuer(D)111K—$00

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-082724) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML